Skip to main content
. 2023 Oct 26;23:785. doi: 10.1186/s12888-023-05285-8

Table 6.

Bivariate analysis of factors influencing HADS-Depression

VARIABLES HADS Depression P Value
Age (correlation) -0,098 0,286
Steroid duration, correlation -0,007 0,94
C3 levels, correlation -0,056 0,546
C4 levels, correlation -0,098 0,287
Mex-SLEDAI 0,031 0,735
Marital Status, median (IQR)
 Unmarried 6 (3) 0,04
 Married 5 (2)
 Divorced 9,5 (4,5)
Organ Involvement,
 Mucocutaneous, median (IQR) 0,247
  Yes 6(3)
  No 5,5 (5,5)
 Musculoskeletal, median (IQR) 0,629
  Yes 6 (3)
  No 5,5 (3)
 Hematology, median (IQR) 0,864
  Yes 6 (3,25)
  No 6 (3)
 Kidney, median (IQR) 0,367
  Yes 6 (2)
  No 6 (3)
 Serositis, median (IQR) 0,847
  Yes 5 (5,5)
  No 6 (3)
DMARD
 Azathioprine, median (IQR) 0,478
  Yes 5,5 (3)
  No 6 (3)
 Cyclosporine, median (IQR) 0,384
  Yes 6 (2,5)
  No 6 (3)
 HCQ, median (IQR) 0,988
  Yes 6 (3)
  No 6 (3)
 Mycophenolate, median (IQR) 0,564
  Yes 6 (4)
  No 6 (2,25)

C3 complement 3, C4 complement 4, DMARD Disease-Modifying Antirheumatic Drugs, HADS A Hospital Anxiety and Depression Scale for anxiety, HADS-D Hospital Anxiety and Depression Scale for depression, HCQ Hydroxychloroquine, Mex SLEDAI Mexican systemic lupus erythematosus systemic disease activity